Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (121K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Sun, Z.
Right arrow Articles by Hampsey, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Z.
Right arrow Articles by Hampsey, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 2560-2566

Footnote

Functional interaction between TFIIB and the Rpb9 (Ssu73) subunit of RNA polymerase II in Saccharomyces cerevisiae

Functional interaction between TFIIB and the Rpb9 (Ssu73) subunit of RNA polymerase II in Saccharomyces cerevisiae Zu-Wen Sun , Amy Tessmer and Michael Hampsey*

Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, Shreveport , LA 71130, USA and Department of Biochemistry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway , NJ 08854, USA

Received March 13, 1996; Revised and Accepted May 14, 1996

ABSTRACT

Recessive mutations in the SSU71 , SSU72 and SSU73 genes of Saccharomyces cerevisiae were identified as either suppressors or enhancers of a TFIIB defect ( sua7-1 ) that confers both a cold-sensitive growth phenotype and a downstream shift in transcription start site selection. The SSU71 ( TFG1 ) gene encodes the largest subunit of TFIIF and SSU72 encodes a novel protein that is essential for cell viability. Here we report that SSU73 is identical to RPB9 , the gene encoding the 14.2 kDa subunit of RNA polymerase II. The ssu73-1 suppressor compensates for both the growth defect and the downstream shift in start site selection associated with sua7-1 . These effects are similar to those of the ssu71-1 suppressor and distinct from the ssu72-1 enhancer. The ssu73-1 allele was retrieved and sequenced, revealing a nonsense mutation at codon 107. Consequently, ssu73-1 encodes a truncated form of Rpb9 lacking the C-terminal 16 amino acids. This Rpb9 derivative retains at least partial function since the ssu73-1 mutant exhibits none of the growth defects associated with rpb9 null mutants. However, in a SUA7 + background, ssu73-1 confers the same upstream shift at ADH1 as an rpb9 null allele. This suggests that the C-terminus of Rpb9 functions in start site selection and demonstrates that the previously observed effects of rpb9 mutations on start site selection are not necessarily due to complete loss of function. These results establish a functional interaction between TFIIB and the Rpb9 subunit of RNA polymerase II and suggest that these two components of the preinitiation complex interact during transcription start site selection.

INTRODUCTION

Accurate initiation of transcription by RNA polymerase II (RNAP II) requires several factors in addition to RNAP II ( 1 ). These general transcription factors (GTFs) include TBP (TATA binding protein), TFIIB, TFIIE, TFIIF and TFIIH (reviewed in 2 , 3 ). The GTFs assemble with RNAP II in a defined order on a DNA template to generate a preinitiation complex (PIC) that is sufficient for accurate, basal level initiation in vitro ( 4 ). Although step by step assembly of the PIC has been demonstrated by several laboratories, the recent identification of RNAP II holoenzyme complexes that include GTFs from both yeast and mammalian cells suggests that RNAP II binds promoters in vivo as a pre-assembled or partially assembled complex ( 5 - 7 ). Several of the GTFs have been shown to be dispensable for accurate initiation in vitro , depending upon the structure of the promoter ( 8 - 12 ). The minimum requirements for accurate initiation from a negatively supercoiled template are TBP, TFIIB and RNAP II, implying that TBP and TFIIB are sufficient to position RNAP II at the transcription start site ( 8 ). TFIIB interacts directly with RNAP II ( 13 , 14 ), as well as with the TBP-TATA complex, binding DNA both upstream and downstream of TATA ( 15 , 16 ). These results are consistent with the suggestion that TFIIB forms a bridge between the TATA element and the initiator region ( 4 ).

Despite identification of the factors required for accurate initiation, the mechanism by which RNAP II selects start sites is unclear. In higher eukaryotes initiation generally occurs at a single start site located ~30 bp from the TATA element, suggesting that start site selection might be defined by a fixed distance from TATA. However, in the yeast Saccharomyces cerevisiae transcription often occurs at multiple sites within a broad window located 40-120 bp from TATA ( 17 , 18 ). Nonetheless, the TATA element in Saccharomyces cerevisiae defines the window within which initiation can occur ( 19 - 23 ).

Genetic analysis of transcription initiation has identified components of the transcriptional machinery that are important for accurate start site selection in S.cerevisiae . The gene encoding yeast TFIIB ( SUA7 ) was first identified based on the ability of sua7 mutations to shift start site selection downstream of normal ( 24 ). Similar effects on start site selection were conferred by sua8 mutations, which are allelic to RPB1 and encode altered forms of the largest subunit (Rpb1) of RNAP II ( 25 ). Mutations in the RPB9 gene, which encodes the 14.2 kDa subunit (Rpb9) of RNAP II, can also affect start site selection, in these cases by shifting transcription initiation upstream of normal ( 26 , 27 ). Mutations in RPB1 can also shift initiation upstream of normal ( 28 ), although the reported effects are more subtle than either the downstream shifts associated with sua7 and sua8 , or the upstream shifts associated with rpb9 . These results demonstrate that TFIIB and the Rpb1 and Rpb9 subunits of RNAP II are important determinants of transcription start site selection in vivo and suggest that accurate initiation involves specific interactions between TFIIB, Rpb1 and Rpb9. Furthermore, these conclusions are consistent with results demonstrating that TFIIB and RNAP II are both necessary and sufficient for accurate start site selection in a yeast in vitro transcription system ( 29 ).

In an effort to identify factors that functionally interact with TFIIB, we are isolating and characterizing suppressors of specific TFIIB defects. The sua7-1 mutation encodes a Glu-62 -> Lys (E62K) replacement that is responsible for both aberrant start site selection and a cold-sensitive (Csm - ) growth defect ( 30 ). By selecting for revertants of the sua7-1 Csm - phenotype, we have identified three genes designated ssu71 , ssu72 and ssu73 . The ssu71 ( TFG1 ) gene encodes the largest subunit of TFIIF and the ssu71-1 suppressor compensates not only for the Csm - phenotype of sua7-1 , but restores the normal initiation pattern in the sua7-1 background ( 31 ). SSU72 is an essential gene encoding a novel factor that functionally interacts with TFIIB ( 32 ). In contrast with ssu71 and ssu73 , the ssu72-1 allele does not suppress sua7-1 . Rather, ssu72-1 , in combination with sua7-1 , confers a heat-sensitive (Tsm - ) growth defect and shifts start site selection further downstream of normal ( 32 ).

Here we define ssu73-1 . This suppressor is similar to the ssu71 suppressors in that it restores growth in the cold and compensates for the downstream start site shift associated with sua7-1 . Molecular and genetic experiments established that ssu73-1 is allelic to RPB9 . These results confirm and extend previous conclusions that the Rpb9 subunit of RNAP II plays an important role in start site selection. Moreover, the genetic relationship between sua7 and ssu73 suggests that interaction between TFIIB and Rpb9 is an important determinant of accurate initiation in vivo .

MATERIALS AND METHODS

Yeast strains

The strains used in this study are listed in Table 1 . Strain YZS19 (Csm + Tsm - ) was isolated as a spontaneous Csm + revertant of YMH71-9C (Csm - Tsm + ). YZS19-3B (Csm + Tsm + ) is a segregant of a diploid strain derived from a cross between YZS19 and YDW546 (Csm - Tsm + ). YAT30 was constructed by introducing plasmid pM706 into strain YDW546. To stimulate integration of RPB9 : URA3 at the RPB9 locus, pM706 was first linearized at the unique Sna BI site located within the Pst I- Bam HI fragment encompassing RPB9 . YZS19 and YZS19-3B derivatives were constructed by introducing the indicated plasmids (YCplac33, pDW11, pM586 or pM681) into the respective strains and selecting for uracil prototrophy.

Genetic methods and nomenclature

Standard procedures were used for crossing yeast strains, selecting diploids, inducing sporulation and dissecting tetrads ( 33 ). Yeast transformations were done by the lithium acetate procedure ( 34 ). The symbols Csm - (cold-sensitive), Tsm - (heat-sensitive) and Slg - (slow growth) refer to distinctly impaired growth (or no growth) on rich medium (YPD) at 16, 37 and 30oC respectively. Ura - denotes failure to grow on -Ura omission medium; Flo - refers to a flocculant growth phenotype in liquid culture (YPD, 30oC).

Plasmids

Plasmids used in this study were constructed by standard recombinant DNA methods ( 35 ). YCplac33 is a centromere-based URA3 vector ( 36 ). pDW11 is a centromere-based URA3 plasmid carrying the SUA7 gene ( 24 ). pM586 carries the 1.05 kb Eco RI- Hin dIII DNA fragment encompassing SSU72 in YCplac33 ( 32 ). pM681 was constructed by transferring the 3.2 kb Pst I- Bam HI fragment encompassing RPB9 from plasmid Ro406 ( 26 ) into YCplac33. pM706 is an integrating plasmid derived by transferring the 3.2 kb Pst I- Bam HI RPB9 fragment into the URA3 integrating vector YIplac211 ( 36 ). Plasmids pM714 and pM715 carry the Eco RI- Spe I DNA fragment encompassing the ssu73-1 open reading frame (amplified by the polymerase chain reaction) in the vectors pRS426 ( 37 ) and pRS314 ( 38 ) respectively.

Table 1 . Yeast strains used in this study
Strain

Genotype

T15

MAT [alpha] CYC1 + cyc7-67 leu2-3,112 ura3-52 cyh2

T16

MAT [alpha] cyc1-5000 cyc7-67 leu2-3,112 ura3-52 cyh2

YDW546

MAT [alpha] cyc1-5000 cyc7-67 leu2-3,112 ura3-52 cyh2 sua7-1

YMH71-9C

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1

YZS19

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu72-1 ssu73-1

YZS19-3B

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu73-1

YZS19/YCplac33

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu72-1 ssu73-1 [ URA3 ]

YZS19/pDW11

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu72-1 ssu73-1 [ URA3 SUA7 ]

YZS19/pM586

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu72-1 ssu73-1 [ URA3 SSU72 ]

YZS19/pM681

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu72-1 ssu73-1 [ URA3 RPB9 ]

YZS19-3B/YCplac33

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu73-1 [ URA3 ]

YZS19-3B/pDW11

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu73-1 [ URA3 SUA7 ]

YZS19-3B/pM586

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu73-1 [ URA3 SSU72 ]

YZS19-3B/pM681

MAT a cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 ssu73-1 [ URA3 RPB9 ]

YAT30

MAT [alpha] cyc1-5000 cyc7-67 leu2-3,112 ura3-52 cyh2 sua7-1 RPB9:URA3

Determination of transcript start sites

Primer extension was performed as described previously, using total RNA and the ADH1 -specific primer oIP-87 ( 24 ). Primer extension products were resolved in a 6% polyacrylamide DNA sequencing gel and visualized by autoradiography. Sequenced SSU72 DNA was used as a molecular size marker.

Cloning and sequencing the ssu73-1 allele

DNA encompassing the ssu73 allele was amplified from genomic DNA (strain YZS19) by the polymerase chain reaction using primers that flank the SSU73 open reading frame. Primers oAT-202 (5'-GG GAATTC CCCTTAAAACTGCTATG) and oAT-203 (5'-TTC ACTAGT GAAAGTTCGTTGAGCACTC) were designed to generate overhanging Eco RI and Spe I restriction endonuclease recognition sites (underlined) respectively. Following amplification, DNA was gel purified, digested with Eco RI and Spe I, and ligated into the vectors pRS426 and pRS314. The resulting plasmids, designated pM714 and pM715 were introduced into Escherichia coli strain XL1-Blue [ recA1 endA1 gyrA96 thi hsdR17 (r K - m K - ) supE44 relA1 lac [F ' : Tn10 proAB lacI q [Delta] (lacZ)M15 ] and single-stranded ssu73 DNA was isolated. The entire ssu73-1 open reading frame was sequenced using M13 universal primers.

RESULTS

Isolation and genetic analysis of an ssu73 mutant

The sua7-1 allele encodes an E62K replacement in TFIIB that confers both altered start site selection and a severe Csm - phenotype ( 30 ). 120 spontaneous Csm + revertants of YMH71-9C ( sua7-1 ) were isolated on rich medium at 16oC. When scored for pleiotropic phenotypes, three Csm + revertants were found to be heat-sensitive (Tsm - ), failing to grow at 37oC. Two of these strains, YZS14 and YZS45, were described previously and are the result of mutations in the SSU71 ( TFG1 ) gene, which encodes the largest subunit of TFIIF ( 31 ). The third strain was designated YZS19 and is depicted in Figure 1 .


Figure 1 . Phenotypes associated with strain YZS19. Growth of strains YMH71-9C ( sua7-1 SSU72 SSU73 ), YZS19 ( sua7-1 ssu72-1 ssu73-1 ) and a diploid strain (2N: sua7-1/sua7-1 ssu72-1/SSU72 ssu73-1/SSU73 ) derived from a backcross of YZS19 with the sua7 mutant, YDW546, are shown on rich medium (YPD) at reduced (16oC), normal (30oC) and elevated (37oC) temperatures. YZS19 was selected as a spontaneous revertant of YMH71-9C on YPD medium at 16oC. Whereas YMH71-9C is phenotypically Csm - and Tsm + , YZS19 is Csm + and Tsm - . Both the Csm + and Tsm - phenotypes of YZS19 are the result of recessive mutations since Csm - and Tsm + were restored when YZS19 was backcrossed with strain YDW546. The Tsm - phenotype of YZS19 is a consequence of the ssu72-1 mutation in combination with sua7-1 , whereas the Csm + phenotype is a consequence of suppression of the sua7-1 mutation by ssu73-1 .

YZS19 was backcrossed with YDW546 ( sua7-1 ) and the resulting diploid strain was phenotypically Csm - and Tsm + , indicating that the Csm + and Tsm - phenotypes of YZS19 are the result of recessive mutation(s) (Fig. 1 ). Tetrad analysis of the same diploid resulted in exclusively two Tsm + : two Tsm - and two Csm + : two Csm - progeny, establishing that the two phenotypes are the result of single gene mutations. However, the Csm + and Tsm - phenotypes did not cosegregate. Therefore, suppression of the sua7-1 Csm - phenotype and acquisition of the Tsm - phenotype are the result of mutations in unlinked genes. This was a surprising result, since both phenotypes arose spontaneously, selecting only for Csm + revertants. When YZS19 (Csm + Tsm - ) was crossed with segregants of the sua7 ssu71 mutant YZS14 (Csm + Tsm - ), the resulting diploids were phenotypically Csm - and Tsm + . The ability of these mutants to cross-complement indicates that neither of the genes uncovered in YZS19 is allelic to SSU71 . We therefore designated these genes SSU72 and SSU73 ; ssu73-1 suppresses the Csm - phenotype and ssu72-1 confers the Tsm - phenotype in the sua7-1 genetic background.

In addition to restoring growth at 16oC, the ssu73-1 mutation was associated with several additional phenotypes. The original sua7-1 mutant was isolated based on its ability to enhance iso-1-cytochrome c expression from the cyc1-5000 allele. This allele is the result of an aberrant ATG codon (uATG) located upstream of the normal ATG start codon, but downstream of the major CYC1 transcription start sites. The sua7-1 -encoded TFIIB defect enhanced iso-1-cytochrome c biosynthesis from <2% to ~30% of normal by shifting transcription initiation downstream of the uATG impediment ( 24 ). Therefore, suppressors of sua7-1 might be expected to diminish iso-1-cytochrome c levels by shifting initiation back upstream of the uATG. Indeed, the iso-1-cytochrome c level in strain YZS19-3B ( sua7 ssu73 ) was diminished from ~30% to 5-10% of normal. Two additional ssu73-1 phenotypes are extreme cell flocculation in liquid culture and suppression of the slow growth phenotype (Slg - ) conferred by sua7-1 at 30oC. These phenotypes are summarized in Table 2 .

Table 2 . Phenotypes associated with the ssu73-1 allele
Strain

Relevant

Phenotypes b

genotype a

Csm

Slg

Flo

Cyt c

T16

cyc1-5000

+

+

+

<2%

YMH71-9C

cyc1-5000 sua7-1

-

+/-

+

~30%

YZS19-3B

cyc1-5000 sua7-1 ssu73-1

+

+

-

5-10%

YZS19-3B/pM681

cyc1-5000 sua7-1 ssu73-1 [ RPB9 ]

-

+/-

+

~30%

a Complete genotypes are listed in Table 1. b Phenotypes are defined as follows: Csm - and Slg - , impaired growth on rich (YPD) medium at 16 and 30oC respectively; Flo - , cell flocculation in liquid YPD medium at 30oC; and Cyt c , iso-1-cytochrome c level, determined by low-temperature, whole-cell spectroscopy and scored relative to a genetically related strain carrying the CYC1 wild-type gene (48).

The ssu73 suppressor is allelic to RPB9

Although the ssu73-1 allele confers multiple phenotypes, we were unable to identify a phenotype, either associated with ssu73 alone or with an sua7 ssu73 double mutant, that could be used to select for the SSU73 wild-type gene from a yeast genomic library. In an effort to avoid cloning SSU73 by scoring a library of transformants for restoration of the Csm - phenotype, we first asked if ssu73 might be allelic to previously cloned yeast genes encoding either general transcription factors or subunits of RNAP II. Since ssu71 is allelic to TFG1 , obvious candidates were TFG2 and TFG3 , the genes encoding the other two subunits of TFIIF ( 39 ). However, neither of these genes complemented ssu73-1. We also tested RPB9 , not only because it encodes a subunit of RNAP II, but because alleles of RPB9 have been reported to affect transcription start site selection ( 26 , 27 ).

To determine whether RPB9 would complement ssu73-1 , a low-copy-number plasmid carrying RPB9 (pM681) was introduced into strain YZS19 ( sua7 ssu72 ssu73 ). A Ura + transformant (YZS19/pM681) was subsequently scored for restoration of Csm - . Strain YZS19/pM681 exhibited the same Csm - phenotype associated with the sua7-1 mutation, whereas control strains that had been transformed with plasmids carrying SUA7 (YZS19/pDW11), SSU72 (YZS19/pM586) or vector only (YZS19/YCplac33) remained Csm + (Fig. 2 ). Plasmid pM681 ( RPB9 ) was also introduced into strain YZS19-3B ( sua7 ssu73 ). The presence of RPB9 restored the Csm - phenotype, elevated iso-1-cytochrome c levels to ~30% of normal, eliminated the flocculant phenotype associated with ssu73-1 , and rendered the strain Slg - at 30oC (Table 2 ). Therefore, RPB9 fully complements all phenotypes associated with the ssu73-1 mutation in the sua7-1 background, suggesting that ssu73-1 is allelic to RPB9 .


Figure 2 . Complementation of ssu73-1 by RPB9 . Low-copy-number URA3 plasmids carrying either SUA7 (pDW11), SSU72 (pM586), RPB9 (pM681) or vector alone (YCplac33) were introduced into strain YZS19 ( sua7 ssu72 ssu73 ). The resulting strains were streaked on -Ura medium and incubated at 16oC. Genetic analysis established that the Csm - phenotype of YZS19 is conferred by sua7-1 and suppressed by ssu73-1 ; ssu72-1 does not affect Csm - (see text). Consistent with these results, plasmid-borne SUA7 eliminated Csm - and neither vector alone nor SSU72 restored Csm - . In contrast, RPB9 fully restored the Csm - phenotype, suggesting that ssu73-1 is allelic to RPB9 .

To confirm that ssu73 is allelic to RPB9 , the RPB9 locus of strain YDW546 ( sua7 SSU73+ ura3 ) was tagged with the URA3 marker by homologous recombination using the RPB9:URA3 integrating plasmid pM706. Integration at the RPB9 chromosomal locus was confirmed by Southern blot analysis (data not shown). One of these strains, designated YAT30 ( sua7 RPB9:URA3 ura3 ), was then crossed with YZS19-3B ( sua7 ssu73 ura3 ), and a resulting diploid was sporulated and dissected. A total of nine tetrads yielding four viable spores were recovered and analyzed. As expected, the Ura + :Ura - and Csm + :Csm - phenotypes segregated 2:2 among all progeny. Moreover, all Ura + segregants ( RPB9 ) were Csm - and all Ura - segregants ( ssu73 ) were Csm + . In addition, the Ura + /Csm - and Ura - /Csm + phenotypes cosegregated among 34 of 36 progeny obtained from additional tetrads yielding either two or three viable spores. The ability of RPB9 to complement ssu73-1 , and segregation of the ssu73 (Csm + Ura - ) and RPB9 (Csm - Ura + ) markers opposite one another, confirms that ssu73-1 is indeed allelic to RPB9 .

Effect of ssu73-1 on transcription start site selection

In addition to its effect on growth at reduced temperature, the sua7-1 mutation shifted transcription start site selection downstream of normal at the ADH1 , CYC1 and other genes ( 24 , 25 ). We therefore asked if ssu73-1 affected start site selection. The ADH1 gene was chosen for this study because both sua7 and rpb9 mutations are known to affect start site selection at ADH1 . Transcription start sites at ADH1 were mapped by primer extension and results are shown in Figure 3 . In a wild-type strain transcription initiates with equal efficiency at two principal sites located 37 and 27 bp upstream of the ATG start codon (lane 1). Consistent with previous results ( 24 , 25 ), the sua7-1 mutation shifted initiation downstream of normal, rendering position -37 a minor site relative to -27 and enhancing initiation at sites downstream of -27 (lane 2). The ssu73-1 mutation partially compensated for the sua7-1 shift (lane 3), resulting in an initiation pattern intermediate between that of the sua7 mutant and the wild-type strain; this effect is most pronounced at position -37 (cf. lane 3 with lanes 2 and 5). In an SUA7 + background, ssu73-1 diminished initiation at the minor sites downstream of -27, enhanced initiation at position -37 relative to -27, and, importantly, generated new sites upstream of -37 (lane 4). The start sites located upstream of -37 are identical to those reported previously for an rpb9 null mutant ( 27 ). These effects can be attributed specifically to ssu73-1 because the downstream shift conferred by sua7-1 (lane 2) is fully restored by plasmid-borne RPB9 ( SSU73 ) in the sua7 ssu73 mutant (lane 5). Therefore, the ssu73-1 mutation exerts an upstream shift on start site selection in both the sua7-1 and SUA7 + backgrounds.


Figure 3 . Primer extension analysis of ADH1 transcription start sites. Lane 1, T15 ( SUA7 SSU73 ); lane 2, YMH71-9C ( sua7-1 SSU73 ); lane 3, YZS19-3B/YCplac33 ( sua7-1 ssu73-1 ); lane 4, YZS19-3B/pDW11 ( sua7-1/SUA7 ssu73-1 ); lane 5, YZS19-3B/pM681 ( sua7-1 ssu73-1 / RPB9 ). Lanes A, C, G and T are molecular size markers and correspond to a sequence ladder of SSU72 DNA. Strain YZS19-3B is a segregant derived from a backcross of YZS19 with YDW546 (Table 1). The principal ADH1 transcription start sites in the wild-type strain (lane 1) are located at positions -37 and -27 (A of the ATG start codon is designated +1). The sua7-1 mutation shifts initiation downstream of normal (lane 2). This effect is partially compensated by the ssu73-1 mutation (position -37, cf. lane 3 with lanes 2 and 5), and the ssu73-1 mutation alone shifts transcription initiation upstream of normal (lane 4). Complementation of the ssu73-1 mutation by plasmid-borne RPB9 ( SSU73 ) in YZS19-3B fully restores the downstream shift associated with sua7-1 (cf. lanes 2 and 5). The starts sites located upstream of position -37 are reproducible and observed only in the ssu73-1 mutant (lane 4). It should be noted, however, that visualization of these sites in lane 4 was augmented here by loading twice the sample volume used in the other lanes. The RNA preparations and primer extensions reactions for all five strains were otherwise identical and directly comparable.

The ssu73-1 mutation

The ssu73-1 allele of RPB9 was cloned by amplification of ssu73 genomic DNA from strain YZS19 by the polymerase chain reaction. Amplified DNA was inserted into the vectors pRS426 and pRS314 and single-stranded DNA was isolated. DNA sequence analysis of the entire ssu73-1 open reading frame revealed a single base-pair substitution encoding a premature stop codon (T C A -> T G A) at the normal serine-107 codon (Fig. 4 ). Therefore, the ssu73-1 suppressor of the TFIIB E62K defect encodes a truncated form of Rpb9 lacking the C-terminal 16 amino acids. This Rpb9 derivative must retain at least partial Rpb9 function since rpb9 null mutants are phenotypically Csm - , Tsm - and Slg - ( 40 ), yet ssu73-1 mutants are not only Tsm + and Slg + , but ssu73-1 was uncovered based on its ability to suppress the sua7-1 Csm - phenotype. Presumably an rpb9 null mutation will also suppress sua7-1 ; however, the Csm - phenotype of rpb9 null mutants precludes testing this possibility.


Figure 4 . The ssu73-1 mutation. The ssu73-1 allele is the result of a nonsense mutation (T C A -> T G A) at codon 107 (Ser -> stop). Consequently, ssu73-1 encodes an Rpb9 derivative lacking the C-terminal 16 amino acids and terminating immediately following the second of two zinc binding motifs. The two Cys 4 zinc binding motifs within Rpb9 encompass residues 7-32 and 75-106 and are denoted by shaded regions. The amino acid sequence of Rpb9 from residue 75 to the C-terminal serine at position 122 are shown using the single letter code; the four cysteine residues that comprise this motif are highlighted.

DISCUSSION

The SSU71 , SSU72 and SSU73 genes were identified based on the ability of recessive mutations at these loci to either suppress ( ssu71 , ssu73 ) or enhance ( ssu72 ) a conditional growth defect associated with the altered form of TFIIB encoded by the sua7-1 allele. SSU71 is identical to TFG1 , the gene encoding the largest subunit of TFIIF ( 31 ). SSU72 is a new gene encoding a novel protein that is essential for cell viability ( 32 ). Here we report that SSU73 is identical to RPB9 , the gene encoding the 14.2 kDa subunit of RNAP II. In addition to either suppressing or enhancing the sua7-1 conditional growth defects, all ssu71 , ssu72 and ssu73 alleles affect transcription start site selection. Both ssu71-1 and ssu73-1 compensate for the downstream shift associated with sua7-1 by at least partially restoring the normal initiation pattern at CYC1 or ADH1 (Fig. 3 ; ref. 31 ). In contrast, ssu72-1 shifts initiation further downstream of normal, a result consistent with identification of ssu72-1 as an enhancer of sua7-1 ( 32 ). These results imply functional interactions between TFIIB/Sua7 and Ssu71/Tfg1, Ssu72 and Ssu73/Rpb9, and that these interactions are important for accurate start site selection in vivo .

Although the ssu71-1 and ssu72-1 mutations exert clear effects on start site selection in the sua7-1 background, neither allele appears to affect initiation in an SUA7+ background (Z.-W.S. and M.H., unpublished results). This is in contrast with ssu73-1 , which shifts initiation at ADH1 upstream of normal in an SUA7+ strain (Fig. 3 ). This upstream shift is consistent with previously reported effects of shi / rpb9 mutations on start site selection ( 26 , 27 , 41 ). Furthermore, the initiation pattern at ADH1 reported here (Fig. 3 , lane 4) appears to be identical to that reported previously for an rpb9 null mutant ( 27 ). Although RPB9 is not essential for cell viability, rpb9 null mutants are severely impaired, exhibiting Csm - , Tsm - and Slg - phenotypes ( 40 ). Since ssu73-1 mutants remain Csm + , Tsm + and Slg + , the ssu73-1 -encoded Rpb9 protein must be functional. Therefore, complete loss of Rpb9 function is not required for altered start site selection; rather an impaired but functional form of Rpb9 is sufficient to shift initiation upstream of normal.

The Rpb9 protein contains two Cys 4 zinc binding motifs, one near the N-terminus, the other near the C-terminus (Fig. 4 ). The C-terminal Cys 4 motif is predicted to form a zinc ribbon, defined as a zinc binding domain comprised of three antiparallel [beta]-sheets, based on sequence similarity to the Cys 4 domain of elongation factor TFIIS ( 42 ). The ssu73-1 allele is the result of a nonsense mutation that encodes a truncated form of Rpb9 lacking the C-terminal 16 amino acid residues (Fig. 4 ). Although this protein retains the four C-terminal cysteine residues, the Cys 4 domain terminates at the fourth cysteine. In the case of TFIIS, the third [beta]-sheet of the zinc ribbon is composed entirely of residues downstream of the fourth cysteine ( 42 ). If this region is critical for formation of the zinc ribbon, then the altered form of Rpb9 encoded by ssu73-1 is unlikely to include an intact zinc ribbon. Thus, the C-terminal 16 amino acids of Rpb9 and, presumably, the C-terminal zinc ribbon are dispensable for normal cell growth. The effect on transcription initiation by the shi allele of RPB9 is due to a C7F replacement in the N-terminal Cys 4 motif ( 26 ), and a C7A replacement has a similar effect on initiation ( 27 ). However, these replacements apparently abolish Rpb9 function since plasmids carrying either allele fail to complement the Tsm - phenotype of an rpb9 null mutant ( 26 , 27 ). Therefore, the N-terminal Cys 4 motif appears to be critical for Rpb9 function but might not be directly involved in transcription start site selection, whereas the C-terminal Cys 4 motif is apparently not essential for Rpb9 function but plays an important role in initiation.

In a yeast in vitro transcription system, replacement of both RNAP II and TFIIB from S.cerevisiae by their counterparts from Schizosaccharomyces pombe is sufficient to shift start sites from the pattern characteristic of S.cerevisiae to that of S.pombe . This result defines TFIIB and RNAP II as the sole determinants of accurate start site selection in vitro ( 29 ). TFIIB is required to recruit RNAP II/TFIIF to the PIC ( 4 ; reviewed in 43 ) and TFIIB directly binds RNAP II in vitro ( 13 ). Mutational analyses have demonstrated that RNAP II interacts with the N-terminal region of TFIIB ( 14 , 44 - 46 ). Previous genetic studies demonstrated that interaction between RNAP II and TFIIB involves the Rpb1 subunit. Double sua7 (TFIIB) sua8 (Rpb1) mutants are inviable (synthetic lethality) and an sua7 / SUA7 sua8 / SUA8 heterozygous diploid strain exhibits mutant phenotypes despite the presence of the dominant, wild-type alleles of both genes (non-allelic non-complementation) ( 25 ). In addition, sua7 and sua8 mutations confer nearly identical effects on start site selection in vivo ( 25 ). These results establish a functional interaction between Rpb1 and TFIIB, and suggest that these two proteins directly interact.

The results presented here extend the functional interaction between RNAP II and TFIIB to include the Rpb9 subunit. However, our genetic data do not rigorously exclude the possibility that the TFIIB and Rpb9 contributions to start site selection are independent of one another. For example, the downstream shift associated with altered TFIIB might be offset by an independent upstream shift associated with altered Rpb9. However, this seems unlikely for several reasons. First, the ADH1 start sites observed upstream of position -37 in the SUA7 + ssu73-1 mutant (Fig. 3 , lane 4) are not seen in the sua7-1 ssu73-1 mutant (lane 3), even upon prolonged exposure of the autoradiogram. If the upstream and downstream shifts were independent of one another, the upstream shift associated with ssu73-1 should be observed in both strains. Secondly, the ssu73-1 effect is not limited to its role in start site selection; rather ssu73-1 is an effective suppressor of the sua7-1 Csm - growth defect (Fig. 1 ). The Csm - phenotype of sua7-1 mutants is presumably a consequence of the altered form of TFIIB on assembly or stability of the PIC ( 32 ), rather than an effect of altered start site selection on the expression of a gene(s) required for growth in the cold. In this case, suppression of the sua7-1 Csm - phenotype by ssu73-1 provides further support for a functional interaction between TFIIB and Rpb9. Finally, given the physical interaction between TFIIB and RNAP II ( 13 ), and the dependence of accurate initiation on this interaction ( 29 ), it is difficult to imagine that the role of Rpb9 in start site selection is independent of TFIIB.

We have failed to detect a direct interaction between Rpb9 and TFIIB and therefore do not know if the functional interaction between these two proteins involves a physical interaction. Moreover, we have failed to detect direct interactions between TFIIB and all three proteins (Ssu71/Tfg1, Ssu72 and Ssu73/Rpb9) identified in our genetic screen for factors that functionally interact with TFIIB (Z.-W.S. and M.H., unpublished results). In this regard it is interesting to note that the zinc binding motifs of both TFIIB and TFIIS are predicted to engage in intramolecular interactions that mask functional domains. The zinc ribbon of TFIIS has been proposed to form a cryptic nucleic acid binding site that is exposed when TFIIS binds an elongation complex ( 42 ). In vitro studies indicate that TFIIB is comprised of a protease-susceptible N-terminus, which includes the zinc binding motif, and a protease-resistant C-terminal core domain ( 46 ). These two domains appear to engage in intramolecular interactions that are disrupted by an activator-induced conformational change, thereby exposing cryptic binding sites for other general transcription factors ( 47 ). Perhaps Ssu71/Tfg1, Ssu72 and Ssu73/Rpb9 interact directly with TFIIB in vivo , but a conformational change in TFIIB is required to expose the interacting domains.

ACKNOWLEDGEMENTS

We are grateful to David Gross for valuable discussions and critical comments on the manuscript. We thank Rolf Furter, Lynn Henry, Roger Kornberg and David Drubin for plasmids carrying the RPB9 , TFG2 and TFG3 / ANC1 genes. This work was supported by research grants from the American Cancer Society (NP-842) and the National Institutes of Health (GM-39484).

REFERENCES

1 Matsui, T., Segall, J., Weil, P. A. and Roeder, R. G. (1980) J. Biol. Chem., 255, 11992-11996. MEDLINE Abstract

2 Buratowski, S. (1994) Cell, 77, 1-3. MEDLINE Abstract

3 Zawel, L. and Reinberg, D. (1995) Annu. Rev. Biochem., 64, 533-561. MEDLINE Abstract

4 Buratowski, S., Hahn, S., Guarente, L. and Sharp, P. A. (1989) Cell, 56, 549-561. MEDLINE Abstract

5 Koleske, A. J. and Young, R. A. (1994) Nature, 368, 466-469. MEDLINE Abstract

6 Kim, Y.-J., Bjorklund, S., Li, Y., Sayre, M. H. and Kornberg, R. D. (1994) Cell, 77, 599-608. MEDLINE Abstract

7 Ossipow, V., Tassan, J.-P., Nigg, E. A. and Schibler, U. (1995) Cell, 83, 137-146. MEDLINE Abstract

8 Parvin, J. D. and Sharp, P. A. (1993) Cell, 73, 533-540. MEDLINE Abstract

9 Parvin, J. D., Shykind, B. M., Meyers, R. E., Kim, J. and Sharp, P. A. (1994) J. Biol. Chem., 269, 18414-18421. MEDLINE Abstract

10 Tyree, C. M., George, C. P., Lira-DeVito, L. M., Wampler, S. L., Dahmus, M. E., Zawel, L. and Kadonaga, J. T. (1993) Genes Dev., 7, 1254-1265. MEDLINE Abstract

11 Goodrich, J. A. and Tjian, R. (1994) Cell, 77, 145-156. MEDLINE Abstract

12 Usheva, A. and Shenk, T. (1994) Cell, 76, 1115-1121. MEDLINE Abstract

13 Tschochner, H., Sayre, M. H., Flanagan, P. M., Feaver, W. J. and Kornberg, R. D. (1992) Proc. Natl Acad. Sci. USA, 89, 11292-11296. MEDLINE Abstract

14 Ha, I., Roberts, S., Maldonado, E., Sun, X., Kim, L. U., Green, M. and Reinberg, D. (1993) Genes Dev., 7, 1021-1032. MEDLINE Abstract

15 Lee, S. and Hahn, S. (1995) Nature, 376, 609-612. MEDLINE Abstract

16 Nikolov, D. B., Chen, H., Halay, E. D., Usheva, A. A., Hisatake, K., Lee, D. K., Roeder, R. G. and Burley, S. K. (1995) Nature, 377, 119-128. MEDLINE Abstract

17 Struhl, K. (1987) Cell, 49, 295-297. MEDLINE Abstract

18 Guarente, L. (1987) Annu. Rev. Genet., 21, 425-452. MEDLINE Abstract

19 Hahn, S., Hoar, E. T. and Guarente, L. (1985) Proc. Natl Acad. Sci. USA, 82, 8562-8566. MEDLINE Abstract

20 Chen, W. and Struhl, K. (1985) EMBO J., 4, 3273-3280. MEDLINE Abstract

21 Nagawa, F. and Fink, G. R. (1985) Proc. Natl Acad. Sci. USA, 82, 8557-8561. MEDLINE Abstract

22 Rudolph, H. and Hinnen, A. (1987) Proc. Natl Acad. Sci. USA, 84, 1340-1344. MEDLINE Abstract

23 Li, W. Z. and Sherman, F. (1991) Mol. Cell. Biol., 11, 666-676. MEDLINE Abstract

24 Pinto, I., Ware, D. E. and Hampsey, M. (1992) Cell, 68, 977-988. MEDLINE Abstract

25 Berroteran, R. W., Ware, D. E. and Hampsey, M. (1994) Mol. Cell. Biol., 14, 226-237. MEDLINE Abstract

26 Furter-Graves, E. M., Hall, B. D. and Furter, R. (1994) Nucleic Acids Res., 22, 4932-4936.

27 Hull, M. W., Mckune, K. and Woychik, N. A. (1995) Genes Dev., 9, 481-490. MEDLINE Abstract

28 Hekmatpanah, D. S. and Young, R. A. (1991) Mol. Cell. Biol., 11, 5781-5791. MEDLINE Abstract

29 Li, Y., Flanagan, P. M., Tschochner, H. and Kornberg, R. D. (1994) Science, 263, 805-807. MEDLINE Abstract

30 Pinto, I., Wu, W. H., Na, J. G. and Hampsey, M. (1994) J. Biol. Chem., 269, 30569-30573. MEDLINE Abstract

31 Sun, Z. W. and Hampsey, M. (1995) Proc. Natl Acad. Sci. USA, 92, 3127-3131. MEDLINE Abstract

32 Sun, Z.-W. and Hampsey, M. (1996) Mol. Cell. Biol., 16, 1557-1566.

33 Sherman, F. and Hicks, J. (1991) Methods Enzymol., 194, 21-37. MEDLINE Abstract

34 Gietz, D., St. John, A., Woods, R. A. and Schiestl, R. H. (1992) Nucleic Acids Res., 20, 1425. MEDLINE Abstract

35 Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn, Cold Spring Harbor Laboratories, Cold Spring Harbor, New York.

36 Gietz, R. D. and Sugino, A. (1988) Gene, 74, 527-534. MEDLINE Abstract

37 Christianson, T. W., Sikorski, R. S., Dante, M., Shero, J. H. and Hieter, P. (1992) Gene, 110, 119-122. MEDLINE Abstract

38 Sikorski, R. S. and Hieter, P. (1989) Genetics, 122, 19-27. MEDLINE Abstract

39 Henry, N. L., Campbell, A. M., Feaver, W. J., Poon, D., Weil, P. A. and Kornberg, R. D. (1994) Genes Dev., 8, 2868-2878. MEDLINE Abstract

40 Woychik, N. A., Lane, W. S. and Young, R. A. (1991) J. Biol. Chem., 266, 19053-19055. MEDLINE Abstract

41 Furter-Graves, E. M., Furter, R. and Hall, B. D. (1991) Mol. Cell. Biol., 11, 4121-4127.

42 Qian, X., Jeon, C., Yoon, H., Agarwal, K. and Weiss, M. A. (1993) Nature, 365, 277-279. MEDLINE Abstract

43 Zawel, L. and Reinberg, D. (1993) Prog. Nucl. Acids Res., 44, 67-108.

44 Buratowski, S. and Zhou, H. (1993) Proc. Natl Acad. Sci. USA, 90, 5633-5637. MEDLINE Abstract

45 Barberis, A., Muller, C. W., Harrison, S. C. and Ptashne, M. (1993) Proc. Natl Acad. Sci. USA, 90, 5628-5632. MEDLINE Abstract

46 Malik, S., Lee, D. K. and Roeder, R. G. (1993) Mol. Cell. Biol., 13, 6253-6259. MEDLINE Abstract

47 Roberts, S. G. E. and Green, M. R. (1994) Nature, 371, 717-720. MEDLINE Abstract

48 Sherman, F. and Slonimski, P. P. (1964) Biochim. Biophys. Acta. 90, 1-15.


Return

*To whom correspondence should be addressed at present address: Department of Biochemistry, Robert Wood Johnson Medical School, UMDNJ, 675 Hoes Lane, Piscataway, NJ 08854, USA
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GENES CELLSHome page
H. Koyama, E. Sumiya, M. Nagata, T. Ito, and K. Sekimizu
Transcriptional repression of the IMD2 gene mediated by the transcriptional co-activator Sub1
Genes Cells, November 1, 2008; 13(11): 1113 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. H. Jenks, T. W. O'Rourke, and D. Reines
Properties of an Intergenic Terminator and Start Site Switch That Regulate IMD2 Transcription in Yeast
Mol. Cell. Biol., June 15, 2008; 28(12): 3883 - 3893.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. A. Khaperskyy, M. L. Ammerman, R. C. Majovski, and A. S. Ponticelli
Functions of Saccharomyces cerevisiae TFIIF during Transcription Start Site Utilization
Mol. Cell. Biol., June 1, 2008; 28(11): 3757 - 3766.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Kasahara, S. Ki, K. Aoyama, H. Takahashi, and T. Kokubo
Saccharomyces cerevisiae HMO1 interacts with TFIID and participates in start site selection by RNA polymerase II
Nucleic Acids Res., March 27, 2008; 36(4): 1343 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Chen, C. Ruggiero, and S. Li
Yeast Rpb9 Plays an Important Role in Ubiquitylation and Degradation of Rpb1 in Response to UV-Induced DNA Damage
Mol. Cell. Biol., July 1, 2007; 27(13): 4617 - 4625.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Li, B. Ding, R. Chen, C. Ruggiero, and X. Chen
Evidence that the Transcription Elongation Function of Rpb9 Is Involved in Transcription-Coupled DNA Repair in Saccharomyces cerevisiae
Mol. Cell. Biol., December 15, 2006; 26(24): 9430 - 9441.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
V. Trinh, M.-F. Langelier, J. Archambault, and B. Coulombe
Structural Perspective on Mutations Affecting the Function of Multisubunit RNA Polymerases
Microbiol. Mol. Biol. Rev., March 1, 2006; 70(1): 12 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Majovski, D. A. Khaperskyy, M. A. Ghazy, and A. S. Ponticelli
A Functional Role for the Switch 2 Region of Yeast RNA Polymerase II in Transcription Start Site Utilization and Abortive Initiation
J. Biol. Chem., October 14, 2005; 280(41): 34917 - 34923.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. A. Freire-Picos, S. Krishnamurthy, Z.-W. Sun, and M. Hampsey
Evidence that the Tfg1/Tfg2 dimer interface of TFIIF lies near the active center of the RNA polymerase II initiation complex
Nucleic Acids Res., September 7, 2005; 33(16): 5045 - 5052.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B.-S. Chen and M. Hampsey
Functional Interaction between TFIIB and the Rpb2 Subunit of RNA Polymerase II: Implications for the Mechanism of Transcription Initiation
Mol. Cell. Biol., May 1, 2004; 24(9): 3983 - 3991.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Ziegler, D. A. Khaperskyy, M. L. Ammerman, and A. S. Ponticelli
Yeast RNA Polymerase II Lacking the Rpb9 Subunit Is Impaired for Interaction with Transcription Factor IIF
J. Biol. Chem., December 5, 2003; 278(49): 48950 - 48956.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. J. Steinmetz and D. A. Brow
Ssu72 Protein Mediates Both Poly(A)-Coupled and Poly(A)-Independent Termination of RNA Polymerase II Transcription
Mol. Cell. Biol., September 15, 2003; 23(18): 6339 - 6349.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Meinhart, T. Silberzahn, and P. Cramer
The mRNA Transcription/Processing Factor Ssu72 Is a Potential Tyrosine Phosphatase
J. Biol. Chem., April 25, 2003; 278(18): 15917 - 15921.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. P. Magill, S. P. Jackson, and S. D. Bell
Identification of a Conserved Archaeal RNA Polymerase Subunit Contacted by the Basal Transcription Factor TFB
J. Biol. Chem., December 7, 2001; 276(50): 46693 - 46696.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. L. Faitar, S. A. Brodie, and A. S. Ponticelli
Promoter-Specific Shifts in Transcription Initiation Conferred by Yeast TFIIB Mutations Are Determined by the Sequence in the Immediate Vicinity of the Start Sites
Mol. Cell. Biol., July 15, 2001; 21(14): 4427 - 4440.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. L. Pappas Jr. and M. Hampsey
Functional Interaction between Ssu72 and the Rpb2 Subunit of RNA Polymerase II in Saccharomyces cerevisiae
Mol. Cell. Biol., November 15, 2000; 20(22): 8343 - 8351.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. A. Hemming and A. M. Edwards
Yeast RNA Polymerase II Subunit RPB9. MAPPING OF DOMAINS REQUIRED FOR TRANSCRIPTION ELONGATION
J. Biol. Chem., January 28, 2000; 275(4): 2288 - 2294.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
W.-H. Wu, I. Pinto, B.-S. Chen, and M. Hampsey
Mutational Analysis of Yeast TFIIB: A Functional Relationship Between Ssu72 and Sub1/Tsp1 Defined by Allele-Specific Interactions With TFIIB
Genetics, October 1, 1999; 153(2): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E.-J. Cho and S. Buratowski
Evidence That Transcription Factor IIB Is Required for a Post-assembly Step in Transcription Initiation
J. Biol. Chem., September 3, 1999; 274(36): 25807 - 25813.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Kershnar, S.-Y. Wu, and C. M. Chiang
Immunoaffinity Purification and Functional Characterization of Human Transcription Factor IIH and RNA Polymerase II from Clonal Cell Lines That Conditionally Express Epitope-tagged Subunits of the Multiprotein Complexes
J. Biol. Chem., December 18, 1998; 273(51): 34444 - 34453.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Martinez, H. Ge, Y. Tao, C.-X. Yuan, V. Palhan, and R. G. Roeder
Novel Cofactors and TFIIA Mediate Functional Core Promoter Selectivity by the Human TAFII150-Containing TFIID Complex
Mol. Cell. Biol., November 1, 1998; 18(11): 6571 - 6583.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. S. Pardee, C. S. Bangur, and A. S. Ponticelli
The N-terminal Region of Yeast TFIIB Contains Two Adjacent Functional Domains Involved in Stable RNA Polymerase II Binding and Transcription Start Site Selection
J. Biol. Chem., July 10, 1998; 273(28): 17859 - 17864.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. Hampsey
Molecular Genetics of the RNA Polymerase II General Transcriptional Machinery
Microbiol. Mol. Biol. Rev., June 1, 1998; 62(2): 465 - 503.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Haviv, M. Shamay, G. Doitsh, and Y. Shaul
Hepatitis B Virus pX Targets TFIIB in Transcription Coactivation
Mol. Cell. Biol., March 1, 1998; 18(3): 1562 - 1569.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
G Orphanides, T Lagrange, and D Reinberg
The general transcription factors of RNA polymerase II.
Genes & Dev., November 1, 1996; 10(21): 2657 - 2683.
[PDF]


Home page
J. Biol. Chem.Home page
S. A. Hemming, D. B. Jansma, P. F. Macgregor, A. Goryachev, J. D. Friesen, and A. M. Edwards
RNA Polymerase II Subunit Rpb9 Regulates Transcription Elongation in Vivo
J. Biol. Chem., November 3, 2000; 275(45): 35506 - 35511.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (121K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Sun, Z.
Right arrow Articles by Hampsey, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Z.
Right arrow Articles by Hampsey, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?